TC
TCON

TFS Capital’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

TFS Capital’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-84
Closed -$82K – 884
2016
Q4 		$82K Buy
+84
New +$96K 0.02% 659
2016
Q1 		– Sell
-52
Closed -$96K – 1117
2015
Q4 		$96K Sell
52
-33
-39% -$66K 0.01% 662
2015
Q3 		$165K Buy
+85
New +$199K 0.02% 765

Other funds holding TCON

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TFS Capital's TCON Position: Q1 2017 in Review

TFS Capital sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q1 2017, closing a stake of 84 shares — an estimated $82K sold.

TFS Capital first reported a position in TCON in Q3 2015 and held it in 3 quarters. The position peaked at $165K in Q3 2015. 22 funds tracked by Wall St. Rank hold TCON as of Q1 2017.

  • TFS Capital reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • TFS Capital sold 84 TRACON Pharmaceuticals, Inc. Common Stock shares in Q1 2017, an estimated $82K.
  • TFS Capital first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q3 2015 and held it in 3 quarters.
  • TFS Capital's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $165K in Q3 2015.
  • 22 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q1 2017.

Based on TFS Capital's 13F filing for Q1 2017, filed 5 May 2017.